NOTCH1 and NOTCH2 mutations have been reported to occur at high frequency in cSCC, shown in studies applying both WES and NGS panels among more than 200 patients combined (50, 54, 64, 70). This evidence concerns the gene NOTCH2 and skin squamous cell carcinoma.